CompletedNot applicableNCT02602652

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Studying Encephalitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chulalongkorn University
Principal Investigator
Pakpoom Janewongwirot, md
Chulalongkorn University
Intervention
a live attenuated chimeric JE vaccine(biological)
Enrollment
50 enrolled
Eligibility
1-5 years · All sexes
Timeline
2013 – 2015

Collaborators

Sanofi Pasteur, a Sanofi Company

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02602652 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis →

← Back to all trials